Figure 3From: Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?Increases in ACR20, ACR50, and ACR70 scores in patients with rheumatoid arthritis who failed previous disease-modifying antirheumatic drug therapy and were given one of four dosages of adalimumab or placebo. Adapted with permission from the BMJ Publishing Group [32].Back to article page